-
Gland Pharma
2,969.85 3,039.00(%) -
Power Fin.Corpn.
357.70 486.45(%) -
IFCI
107.45 107.45(%) -
Shriram Finance
1,036.40 584.25(%) -
Tata Technolog.
796.45 507.50(%) -
ESDS Software
895.55 895.55(%) -
Lenskart Solut.
694.75 694.75(%) -
Netweb Technol.
5,170.00 2,514.75(%) -
Lumino Inds
122.00 122.00(%) -
Kesar India
1,180.00 1,341.00(%) -
Multi Comm. Exc.
3,287.00 3,479.80(%) -
Tejas Networks
623.90 644.75(%) -
RBL Bank
417.00 417.00(%) -
ICICI AMC
2,960.00 2,528.90(%) -
Polycab India
8,254.00 6,660.50(%) -
New India Assura
234.60 234.60(%) -
Wockhardt
2,107.95 2,420.00(%) -
Angel One
308.20 360.20(%) -
Jindal Worldwide
57.06 57.06(%) -
Lalithaa Jewel
308.55 308.55(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Kronox Lab Sciences Ltd Chemicals
- Indian Private
- BSE Code : 92547.0
- ISIN : INE0ATZ01017
-
Today’s Low
182.00 -
Today’s High
189.00
-
Open
182.45 -
Perv Close
183.37 -
52W Low
96.00 -
52W High
223.42
Key Indicators
-
P/E(TTM)
23.92
-
Mar.Cap (₹Cr.)
685.27
-
Div & Yield %
0.27
-
Book Value(₹)
31.30
-
Debt-Equity Ratio
0.72
-
AGM Date
04-Sep-2026
-
EPS
7.70
-
P/E Ratio
23.92
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
685.27
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
37.10
-
BV (₹)
31.30
-
Sales( ₹ in Cr.)
101.22
-
NP (in Cr.)
27.60
-
NP Var(%)
8.0
-
Div%
5.0
-
CPS (₹)
8.00
-
EPS (₹)
7.40
-
Traded Value (₹ in Lakhs)
683.27
-
52 Week High
223.42
-
52 Week Low
96.00
-
Price BSE
184.0
-
Price NSE
185.00
-
Market Capital( in Cr.)
683.27
-
P/C Ratio
23.00
-
P/E Ratio
24.70
-
Price Vs.BV
7.40
-
24-Aug-2026( 11:08)
Corporate News - KRONO... - KRONOX Lab Sciences Limited in...
-
21-Aug-2026( 09:18)
Corporate News - Indo... - Indo Borax and Chemicals Limit...
-
20-Aug-2026( 08:17)
Corporate News - Indo... - Indo Borax and Chemicals Limit...
-
13-Aug-2026( 12:37)
Corporate News - KRONO... - KRONOX Lab Sciences Limited in...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 101.22 | 100.19 | 89.86 | 95.58 | 82.25 | 62.46 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 101.22 | 100.19 | 89.86 | 95.58 | 82.25 | 62.46 |
| Other Income | 5.19 | 2.53 | 1.58 | 1.92 | 1.09 | 0.78 |
| Stock Adjustments | 0.56 | -2.25 | -0.96 | 3.13 | 0.58 | -0.05 |
| Total Income | 106.97 | 100.47 | 90.48 | 100.63 | 83.92 | 63.19 |
| EXPENDITURE : | ||||||
| Raw Materials | 47.14 | 47.24 | 44.89 | 58.01 | 47.98 | 34.36 |
| Power and Fuel Cost | 2.06 | 1.99 | 0.59 | 0.54 | 0.48 | 0.41 |
| Employee Cost | 3.44 | 2.95 | 2.50 | 1.93 | 1.65 | 1.49 |
| Other Manufacturing Expenses | 7.64 | 7.74 | 5.96 | 5.03 | 3.87 | 4.16 |
| Selling and Administration Expenses | 6.34 | 4.01 | 6.18 | 10.55 | 8.81 | 6.91 |
| Miscellaneous Expenses | 0.89 | 0.89 | 0.45 | 0.94 | 0.35 | 0.28 |
| Employee Benefit Expenses | 3.44 | 2.95 | 2.50 | 1.93 | 1.65 | 1.49 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 67.51 | 64.81 | 60.58 | 77.00 | 63.13 | 47.61 |
| Operating Profit | 39.46 | 35.65 | 29.90 | 23.63 | 20.79 | 15.58 |
| Interest | 0.11 | 0.00 | 0.00 | 0.09 | 0.41 | 0.38 |
| Gross Profit | 39.35 | 35.65 | 29.90 | 23.54 | 20.38 | 15.20 |
| Depreciation | 2.05 | 1.38 | 1.29 | 1.50 | 2.03 | 1.98 |
| Profit Before Tax | 37.30 | 34.27 | 28.61 | 22.04 | 18.35 | 13.22 |
| Current Tax | 9.72 | 8.88 | 7.35 | 5.72 | 4.79 | 3.55 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.08 | -0.08 | -0.09 | -0.08 | -0.06 | -0.06 |
| Reported Net Profit | 27.66 | 25.47 | 21.35 | 16.40 | 13.63 | 9.73 |
| Extraordinary Items | 0.06 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
| Adjusted Net Profit | 27.60 | 25.47 | 21.35 | 16.39 | 13.61 | 9.71 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | -51.30 | 0.00 | -6.18 |
| P & L Balance brought forward | 50.54 | 26.93 | 5.58 | 40.48 | 26.56 | 23.02 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1.85 | 1.85 | 0.00 | 0.00 | 0.00 | 0.01 |
| P & L Balance carried down | 76.35 | 50.54 | 26.93 | 5.58 | 40.19 | 26.56 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 5.00 | 5.00 | 5.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.50 | 0.50 | 0.50 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 7.45 | 6.86 | 5.75 | 4.42 | 565.44 | 403.73 |
| Earnings Per Share(Adj)-Unit Curr | 7.45 | 6.86 | - | - | - | - |
| Book Value | 31.30 | 24.28 | 17.87 | 12.06 | 1,674.40 | 1,112.61 |
| Book Value(Adj)-Unit Curr | 31.30 | 24.28 | - | - | - | - |
